To further explore the therapeutic potential of the NDI, we assessed its cytotoxic activity in an in vitro model of estrogen-receptor positive breast cancer (BCa), a tumor type for which anti-RET therapy may represent a novel treatment option [20]. Here, RET is linked to neoplasm.